Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.

Literature DB >> 29350080

IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.

Samir Mazharuddin¹, Anuja Chattopadhyay², Moshe Y Levy¹, Robert L Redner².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29350080 PMCID： PMC6162987 DOI： 10.1080/10428194.2017.1421761

Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022

× No keyword cloud information.

18 in total

1. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.

Authors: E G van Lochem; V H J van der Velden; H K Wind; J G te Marvelde; N A C Westerdaal; J J M van Dongen
Journal: Cytometry B Clin Cytom Date: 2004-07 Impact factor: 3.058

2. The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.

Authors: Takeshi Kondo; Akio Mori; Stephanie Darmanin; Satoshi Hashino; Junji Tanaka; Masahiro Asaka
Journal: Haematologica Date: 2008-07-04 Impact factor: 9.941

3. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia.

Authors: J V Jovanovic; M C Chillón; C Vincent-Fabert; R Dillon; E Voisset; N C Gutiérrez; R G Sanz; A A M Lopez; Y G Morgan; J Lok; E Solomon; E Duprez; M G Díaz; D Grimwade
Journal: Leukemia Date: 2016-11-22 Impact factor: 11.528

4. GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid.

Authors: Ji Li; Hai-Ying Zhong; Yang Zhang; Le Xiao; Li-Hong Bai; Su-Fang Liu; Guang-Biao Zhou; Guang-Sen Zhang
Journal: Br J Haematol Date: 2014-10-04 Impact factor: 6.998

5. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Authors: S Castaigne; C Chomienne; M T Daniel; P Ballerini; R Berger; P Fenaux; L Degos
Journal: Blood Date: 1990-11-01 Impact factor: 22.113

6. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.

Authors: Yirui Chen; Shouyun Li; Chunlin Zhou; Chengwen Li; Kun Ru; Qing Rao; Haiyan Xing; Zheng Tian; Kejing Tang; Yingchang Mi; Baohong Wang; Min Wang; Jianxiang Wang
Journal: Blood Date: 2014-04-29 Impact factor: 22.113

7. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.

Authors: Yukiya Yamamoto; Sachiko Tsuzuki; Motohiro Tsuzuki; Kousuke Handa; Yoko Inaguma; Nobuhiko Emi
Journal: Blood Date: 2010-08-31 Impact factor: 22.113

8. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

Authors: H de Thé; C Lavau; A Marchio; C Chomienne; L Degos; A Dejean
Journal: Cell Date: 1991-08-23 Impact factor: 41.582

9. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.

Authors: R L Redner; E A Rush; S Faas; W A Rudert; S J Corey
Journal: Blood Date: 1996-02-01 Impact factor: 22.113

10. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

Authors: Z Chen; N J Brand; A Chen; S J Chen; J H Tong; Z Y Wang; S Waxman; A Zelent
Journal: EMBO J Date: 1993-03 Impact factor: 11.598

9 in total

1. Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.

Authors: Ragnar O Vilmundarson; Niloufar Heydarikhorneh; An Duong; Tiffany Ho; Kianoosh Keyhanian; Fariborz Soheili; Hsiao-Huei Chen; Alexandre F R Stewart
Journal: Front Immunol Date: 2022-07-04 Impact factor: 8.786

2. Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts.

Authors: Jana M Ellegast; Gabriela Alexe; Amanda Hamze; Shan Lin; Hannah J Uckelmann; Philipp J Rauch; Maxim Pimkin; Linda S Ross; Neekesh V Dharia; Amanda L Robichaud; Amy Saur Conway; Delan Khalid; Jennifer A Perry; Mark Wunderlich; Lina Benajiba; Yana Pikman; Behnam Nabet; Nathanael S Gray; Stuart H Orkin; Kimberly Stegmaier
Journal: Cancer Discov Date: 2022-07-06 Impact factor: 38.272

Review 3. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors: Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal: Biomark Res Date: 2021-05-06

4. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.

Authors: Yiping Liu; Fang Xu; Hong Hu; Jingjing Wen; Jing Su; Qiaolin Zhou; Wen Qu
Journal: Onco Targets Ther Date: 2019-08-02 Impact factor: 4.147

Review 5. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Authors: Marta Sobas; Maria Carme Talarn-Forcadell; David Martínez-Cuadrón; Lourdes Escoda; María J García-Pérez; Jose Mariz; María J Mela-Osorio; Isolda Fernández; Juan M Alonso-Domínguez; Javier Cornago-Navascués; Gabriela Rodríguez-Macias; María E Amutio; Carlos Rodríguez-Medina; Jordi Esteve; Agnieszka Sokół; Thais Murciano-Carrillo; María J Calasanz; Manuel Barrios; Eva Barragán; Miguel A Sanz; Pau Montesinos
Journal: Cancers (Basel) Date: 2020-05-21 Impact factor: 6.639

6. Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish definitive myelopoiesis.

Authors: Luxiang Wang; Shuo Gao; Haihong Wang; Chang Xue; Xiaohui Liu; Hao Yuan; Zixuan Wang; Saijuan Chen; Zhu Chen; Hugues de Thé; Yiyue Zhang; Wenqing Zhang; Jun Zhu; Jun Zhou
Journal: Haematologica Date: 2020-01-31 Impact factor: 9.941

IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.

1. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.

2. The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.

3. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia.

4. GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid.

5. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

6. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.

7. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.

8. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

9. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.

10. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia.

1. Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.

2. Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts.

Review 3. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

4. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.

Review 5. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

6. Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish definitive myelopoiesis.

Review 7. Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Review 8. Classic and Variants APLs, as Viewed from a Therapy Response.

Review 9. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene.

Review 3. Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Review 5. PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Review 7. Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Review 8. Classic and Variants APLs, as Viewed from a Therapy Response.

Review 9. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene.

Review 5. PLZF-RAR_α, NPM1-RAR_α, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.